Trials / Completed
CompletedNCT01191359
Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch
A Multicentre Randomised Phase II Clinical Pilot Study to Compare the Pharmacodynamic Efficacy and Tolerability of the Sublingual and the Vestibular Administration Route for SLITonePLUS® Birch
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- ALK-Abelló A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Multicentre Phase II trial, comparing two different administration routes of SLITonePLUS Birch in regard to pharmacodynamic efficacy and tolerability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | oral immunotherapy | orally applied specific immunotherapy |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2010-08-30
- Last updated
- 2013-02-08
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01191359. Inclusion in this directory is not an endorsement.